Recursion Pharmaceuticals Pre-Tax Profit Margin 2020-2024 | RXRX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Recursion Pharmaceuticals pre-tax profit margin from 2020 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.

Recursion Pharmaceuticals Pre-Tax Profit Margin 2020-2024 | RXRX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Recursion Pharmaceuticals pre-tax profit margin from 2020 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Zoetis (ZTS)	$78.5B
Takeda Pharmaceutical (TAK)	$43.1B
Merck (MKKGY)	$20.8B
Astellas Pharma (ALPMY)	$19.8B
Sandoz Group AG (SDZNY)	$19.4B
United Therapeutics (UTHR)	$17.9B
Summit Therapeutics (SMMT)	$15.3B
Neurocrine Biosciences (NBIX)	$12.9B
Shionogi (SGIOY)	$12.2B
Catalent (CTLT)	$10.8B
Jazz Pharmaceuticals (JAZZ)	$7.7B
Madrigal Pharmaceuticals (MDGL)	$7.4B
Orion OYJ (ORINY)	$6.7B
Corcept Therapeutics (CORT)	$6.1B
Ionis Pharmaceuticals (IONS)	$6B
Crinetics Pharmaceuticals (CRNX)	$4.7B
PTC Therapeutics (PTCT)	$3.4B
Dyne Therapeutics (DYN)	$2.9B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.9B
Catalyst Pharmaceuticals (CPRX)	$2.7B
Arrowhead Pharmaceuticals (ARWR)	$2.7B
Soleno Therapeutics (SLNO)	$2.5B
NewAmsterdam Pharma (NAMS)	$2.2B
Centessa Pharmaceuticals (CNTA)	$1.9B
Harrow (HROW)	$1.8B
Xencor (XNCR)	$1.7B
Ocular Therapeutix (OCUL)	$1.7B
BioCryst Pharmaceuticals (BCRX)	$1.6B
ARS Pharmaceuticals (SPRY)	$1.6B
Evotec AG (EVO)	$1.6B